The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Workshop of the Carolinas 2024 | MPNs in pediatric and AYA patients
Nicole Kucine, MD, MS, Weill Cornell Medicine, New York, NY, summarizes her talk on myeloproliferative neoplasms (MPNs) in pediatric and adolescent and young adult (AYA) patients. Dr Kucine highlights that essential thrombocythemia (ET) is the most common MPN in pediatric patients and that triple-negative MPNs are more frequent in younger patients than their adult counterparts. The talk also covered other important aspects, such as the risk of thrombosis, disease transformation, and considerations for treatment. Dr Kucine also emphasizes the need to educate clinicians on the transition from pediatric to adult care, outlining some key considerations. This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultancy: PharmaEssentia, Protagonist Therapeutics; Conference speaker: AOP Health.
